FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Appco Pharma Ranitidine Capsules 300 mg Recall

Ranitidine Capsules 300 mg, 30 count bottles

Appco Pharma LLC · Piscataway, NJ

Risk level
Class II
Reported by FDA
Jan 15, 2020
Recall ID
D-0648-2020
Check your lot numberHow we source this data

Summary

Appco Pharma recalled Ranitidine Capsules 300 mg starting Jan 7, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0648-2020 on Jan 15, 2020. Reason: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API. Status: Terminated.

Why it was recalled

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Product description

Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623, NDC 62559-691-30.

Lot numbers, UPCs & expiration codes

Batch # 1905227UE, exp. date Apr-2021 1905228UE, exp. date Apr-2021

Where it was sold

Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0648-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 7, 2020
FDA report date
Jan 15, 2020
Quantity
1,632 bottes
Recall type
Voluntary: Firm initiated
Recalling firm
Appco Pharma LLC

Original FDA data

Every field from FDA enforcement report D-0648-2020, exactly as published.

Show all FDA fields
City
Piscataway
State
NJ
Status
Terminated
Country
United States
Event ID
84610
Address
262 Old New Brunswick Rd Unit N
Code information
Batch # 1905227UE, exp. date Apr-2021 1905228UE, exp. date Apr-2021
Postal code
08854-3756
Report date
Jan 15, 2020
Product type
Drugs
Recall number
D-0648-2020
Classification
Class II
Recalling firm
Appco Pharma LLC
Product quantity
1,632 bottes
Termination date
Apr 24, 2020
Reason for recall
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623, NDC 62559-691-30.
Distribution pattern
Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.
Recall initiation date
Jan 7, 2020
Initial firm notification
Press Release
Center classification date
Jan 7, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0648-2020, published Jan 15, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls